Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Disease × Dexamethasone × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 39 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Leukemia 16 Lymphoma 11 Neoplasms, Plasma Cell 5 Hodgkin Disease 5 Burkitt Lymphoma 5 Recurrence 4 Waldenstrom Macroglobulinemia 3 Leukemia, Biphenotypic, Acute 3 Vomiting 2 Prostatic Neoplasms 2 Nausea 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Immunoglobulin Light-chain Amyloidosis 2 Uterine Cervical Neoplasms 1 Thrombocytopenia 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Seminoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neutropenia 1 Neoplasms, Neuroepithelial 1 Neoplasms 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1

Interventions

Cyclophosphamide 2 deltacortene 1 daratumumab 1 carfilzomib 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Dexamethasone 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02204241 2023-07-03

CCD

European Myeloma Network B.V.

Phase 1/2 Completed

Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡